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Pancreatico-pleural ﬁstula is an uncommon cause of recurrent pleural effusion. Delayed diagnosis may
occur if ﬂuid amylase level is not obtained early in the clinical course. As most cases of pancreatico-
pleural effusion are due to chronic pancreatitis, endoscopic therapy may be effective if pancreatic ﬂuid
secretion can be diverted to a more physiologic pathway. However, when severe pancreatitis leads to
disconnection of the pancreatic duct, it precludes conventional endoscopic treatment via transpapillary
stenting of the pancreatic duct. We describe a patient with a chronic, refractory pancreatico-pleural
ﬁstula arising from chronic pancreatitis with a disconnected pancreatic duct syndrome, which
resolved following endoscopic ultrasound-guided therapy.
 2013 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Pancreatico-pleural ﬁstula (PPF) is a rare cause of recurrent,
large pleural effusions, usually resulting from chronic pancrea-
titis.1e5 We report a unique case of successful resolution of PPF
following endoscopic ultrasound (EUS)-guided therapy.
2. Case report
2.1. Patient presentation
A 58-year-old womanwith a 30-pack-year smoking history and
remote alcoholism presented with dyspnea due to large pleural
effusions (Fig. 1).
She had a remote history of abdominal pain but no current pain
or diarrhea. Over a period of four months, she underwent 4 large-
volume thoracenteses, 2 chest tube placements and 2 thoracot-
omies for recurrent effusions; the etiology remained obscure until
the 4th thoracentesis, when ﬂuid amylase was measured and found
to be markedly elevated (29,503 U/L).Associates, Ltd., 401 Roxbury
7340; fax: þ1 815 397 7388.
, bjuhlin@rockfordgi.com
-NC-ND license.2.2. Imaging studies
Chest radiography revealed pleural effusions. Magnetic reso-
nance cholangio-pancreatography (MRCP) showed an irregular
pancreatic duct with non-visualization of the tail portion, and two
small adjacent ﬂuid collections (Fig. 2).2.3. Endoscopic management
A one-week trial of medical therapy with bowel rest and
octreotide afforded no improvement in the pleural effusion(s). The
patient was not considered a candidate for surgical therapy.
Therefore, management with endoscopic retrograde cholangio-
pancreatography (ERCP) and EUS was performed. ERCP conﬁrmed
the MRCP ﬁndings of ductal disruption with a disconnected
pancreatic tail; the sub-diaphragmatic pancreatic ﬂuid collection
did not opacify with retrograde injection of contrast (Fig. 3). A
transpapillary 7-French, single-pigtail stent (Hobbs Medical Co.,
Stafford Springs, CT, USA) was placed to facilitate drainage of the
body and head of pancreas. EUS was performed using a linear-array
echoendoscope (Olympus Corporation, Tokyo, Japan). The sub-
diaphragmatic pancreatic ﬂuid collection, attributable to the
disconnected pancreatic tail, was targeted for EUS-guided therapy.
Utilizing conventional techniques of EUS-guided pseudocyst
drainage,6 the collection was accessed via transgastric needle
puncture (Echo-tip 19-gauge needle, Cook Medical, Bloomington,
Fig. 1. Presenting anterioreposterior CXR showing large pleural effusion.
Fig. 3. ERCP with pancreatic wire cannulation demonstrating non-ﬁlling (discon-
nected) tail portion of pancreatic duct. There is opaciﬁcation of the smaller ﬂuid
collection seen on MRCP (arrow), indicating communication with main pancreatic
duct.
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aspiration followed by contrast injection under ﬂuoroscopy (Fig. 4).
A 0.035 guide-wirewas passed through the needle and coiled in the
cavity of the collection (Fig. 5). The transgastric tract was dilated to
8 mm using a balloon catheter. Two 5-cm double-pigtail Solus
stents (Cook Medical) were placed, each with one pigtail within the
collection and the other within the gastric lumen (Figs. 6).
2.4. Patient outcome
Plain X-rays obtained 12 days after the endoscopic procedures
demonstrated spontaneous passage of the transpapillary pancre-
atic stent, stable position of the transgastric stents and resolution ofFig. 2. MRCP demonstrating normal proximal pancreatic duct (arrow), non-ﬁlling of
disconnected tail portion of pancreatic duct and adjacent pancreatic ﬂuid collections
(arrowheads).pleural effusions. At 5-month follow-up the patient was asymp-
tomatic without clinical or radiographic evidence of recurrent
effusions; transgastric stents remained in stable position in the
region of the gastric fundus (Fig. 7). Repeat MRCP showed resolu-
tion of peri-pancreatic ﬂuid collections.Fig. 4. EUS-guided wire cannulation of larger (disconnected) pancreatic ﬂuid collec-
tion, which opaciﬁed only with EUS-guided transgastric contrast injection but not with
transpapillary injection, consistent with ductal discommunication.
Fig. 5. EUS-guided wire cannulation of large pancreatic ﬂuid collection.
Fig. 7. Chest X-ray 5 months post endoscopic treatment of pancreatico-pleural ﬁstula.
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PPFs occur in 0.4%e4.5% of patients with pancreatitis.1 PPF can
arise from surgical procedures or trauma; more commonly it re-
sults from chronic pancreatitis with pancreatic duct disruption.1e5
Transdiaphragmatic ﬁstulous tracts allow communication be-
tween the peri-pancreatic retroperitoneal space and the pleural
cavity, leading to large-volume pleural effusions.7Fig. 6. Endoscopic view following EUS-guided placement of transgastric double-pigtail
stents.PPF may be diagnostically challenging because patients present
with respiratory rather than abdominal symptoms.1e5 Accordingly,
chest radiography is typically the initial diagnostic study. Diagnosis
of PPF can be secured by pleural ﬂuid amylase elevation typically in
the many thousands, and by radiographic imaging for a ﬁstulous
tract. The differential diagnosis of elevated pleural amylase include
lung adenocarcinoma, female genital cancers, other solid organ
cancers, esophageal rupture, and pancreatic disease.3 MRCP is a
useful imaging study since it allows complete imaging of the
pancreatic duct, whereas ERCP cannot deﬁne ductal anatomy up-
stream of the disruption and associated pathology.5,7,8
Management of PPF includes thoracentesis, parenteral nutrition,
and octreotide, which are effective in 40e60% of cases.9e11 If con-
servative therapy fails, additional therapy is indicated. Options
include percutaneous drainage, surgery, and endoscopic manage-
ment. Endoscopic strategies strive to divert the anomalous
pancreatic secretions toward the gastrointestinal lumen. When the
pancreatic duct is intact, transpapillary stenting of the pancreatic
duct has been employed successfully.8,10 However, when a
disconnected pancreatic duct leads to PPF as in our case, trans-
papillary stenting alone would only be expected to be efﬁcacious if
the disrupted duct can be bridged by the stent, a notoriously
challenging undertaking.12 In the present case EUS-guided therapy
effectively addressed both the disconnected pancreatic duct and
the PPF. Others have reported successful results with EUS-guided
treatment for disconnected pancreatic duct syndrome.12,13 How-
ever, to our knowledge, ours is the ﬁrst reported case of EUS-guided
therapy for PPF.
Surgical management of PPF entails pancreatectomy with
splenectomy, pancreaticoduodenectomy, or pancreatic duct anas-
tomosis to a loop of small intestine requiring an average hospital
stay of 16 days.14 Reported complications from surgical
M.D. Houlihan et al. / Respiratory Medicine Case Reports 9 (2013) 30e33 33management include wound dehiscence and intra-abdominal ﬂuid
collection requiring surgical drainage.14 Successful EUS-guided
treatment of PPF as described herein was accomplished with a
48-h hospital stay and avoided unnecessary loss of pancreatic or
splenic function as well as the morbidity associated with laparot-
omy. Potential complications in the endoscopic management of PPF
are empyema15 and small bowel obstruction related to stent
migration.16 Empyema can be successfully managed with mini-
mally invasive thoracotomy and laparotomy.15 Small bowel
obstruction due to stent migration is uncommon and often can be
managed non-surgically.16 The pigtail conﬁguration of the stent
acts as an anchor which resists migration. Material pliability, small
caliber, and curvilinear poles are intrinsic properties of the double-
pigtail stent which typically allow uneventful passage of migrated
stents through the gastrointestinal tract.
Management of PPF requires a thoughtful multidisciplinary
approach tailored to the individual patient and availability of
endoscopic as well as surgical expertise. We believe our technique
of EUS-guided therapy for PPF due to disconnected pancreatic duct
syndrome is an appealing minimally invasive alternative to surgical
therapy.4. Conclusions
PPF is an unusual complication of chronic pancreatitis that
should be recognized promptly if thoracentesis yields amylase-rich
ﬂuid. This case demonstrated effective EUS-guided therapy for a
chronic PPF associated with chronic pancreatitis and disconnected
pancreatic duct syndrome.Conﬂict of interest
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